Bridgebio Pharma Shares Rise 0.28% to $68.56 Amid Strong 24‑Hour Volume
Bridgebio Pharma stock closes 0.28% higher at $68.56, 52‑week high $93.42, with a market cap of $13.2B. Get the latest trading data, volume, and performance insights.
- BRIDGEBIO PHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read

